Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.61 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.51 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.51 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.51 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.50 |
| ▸ | PTAFR | P25105 | 1/20 | 0.50 |
| ▸ | HTR1D | P28221 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.50 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3861371 | 1.00 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2NR5A2NR5A1MEN1 | |
| SCHEMBL6027169 | 0.97 | ALDH1A1 (0.69) | ALDH1A1SMN1; SMN2NR5A2NR5A1MEN1 | |
| SCHEMBL17065552 | 0.94 | SMN1; SMN2 (0.67) | ALDH1A1SMN1; SMN2NR5A2NR5A1MEN1 | |
| SCHEMBL825278 | 0.94 | SMN1; SMN2 (0.67) | ALDH1A1SMN1; SMN2NR5A2NR5A1MEN1 | |
| SCHEMBL6912576 | 0.93 | SMN1; SMN2 (0.61) | ALDH1A1SMN1; SMN2NR5A2NR5A1MEN1 | |
| SCHEMBL10693602 | 0.85 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2NR5A2NR5A1MEN1 | |
| Phosphocholine SCHEMBL3713381 | 0.84 | S1PR1 (0.53) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| Phosphocholine SCHEMBL5087547 | 0.84 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2NR5A2NR5A1MEN1 | |
| SCHEMBL3406019 | 0.83 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1MEN1 | |
| SCHEMBL3410573 | 0.83 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024500-A1 | METHODS AND SYSTEMS FOR TRANSDERMAL IMMUNOTHERAPY | Passport Technologies, Inc. (US) | 2025-01-30 | — | — | WO | claimed |
| EP-3976092-A1 | COMPOSITION AND METHOD FOR SPRAY DRYING AN ADJUVANT VACCINE EMULSION | Infectious Disease Research Institute (US) | 2022-04-06 | — | — | EP | claimed |
| EP-3853202-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | ModernaTX, Inc. (US) | 2021-07-28 | — | — | EP | claimed |
| WO-2020257260-A1 | FORMULATION OF PEPTIDE LOADED LIPOSOMES AND RELATED APPLICATIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-12-24 | — | — | WO | claimed |
| WO-2020243115-A1 | COMPOSITION AND METHOD FOR SPRAY DRYING AN ADJUVANT VACCINE EMULSION | INFECTIOUS DISEASE RESEARCH INSTITUTE (US) | 2020-12-03 | — | — | WO | claimed |
| WO-2020061367-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | MODERNATX, INC. (US) | 2020-03-26 | — | — | WO | claimed |
| WO-2019010521-A1 | THIN FILM VORTEX FLUIDIC FABRICATION OF LIPOSOMES | FLINDERS UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2019-01-17 | — | — | WO | claimed |
| EP-3277263-A1 | LIPID PARTICLE FORMULATIONS FOR DELIVERY OF RNA AND WATER-SOLUBLE THERAPEUTICALLY EFFECTIVE COMPOUNDS TO A TARGET CELL | BioNTech RNA Pharmaceuticals GmbH (DE) | 2018-02-07 | — | — | EP | claimed |
| WO-2016156398-A1 | LIPID PARTICLE FORMULATIONS FOR DELIVERY OF RNA AND WATER-SOLUBLE THERAPEUTICALLY EFFECTIVE COMPOUNDS TO A TARGET CELL | BIONTECH RNA PHARMACEUTICALS GMBH (DE) | 2016-10-06 | — | — | WO | claimed |
| WO-2016155809-A1 | LIPID PARTICLE FORMULATIONS FOR DELIVERY OF RNA AND WATER-SOLUBLE THERAPEUTICALLY EFFECTIVE COMPOUNDS TO A TARGET CELL | BIONTECH RNA PHARMACEUTICALS GMBH (DE) | 2016-10-06 | — | — | WO | claimed |
| EP-1478341-A4 | EFFICIENT NUCLEIC ACID ENCAPSULATION INTO MEDIUM SIZED LIPOSOMES | TRANSAVE INC (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2006130177-A1 | PARTICULATE-STABILIZED INJECTABLE PHARMACEUTICAL COMPOSITIONS OF POSACONAZOLE | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | claimed |
| EP-1478341-A1 | EFFICIENT NUCLEIC ACID ENCAPSULATION INTO MEDIUM SIZED LIPOSOMES | Elan Pharmaceuticals, Inc. (US) | 2004-11-24 | — | — | EP | claimed |
| WO-2003059322-A1 | EFFICIENT NUCLEIC ACID ENCAPSULATION INTO MEDIUM SIZED LIPOSOMES | ELAN PHARMACEUTICALS, INC. (US) | 2003-07-24 | — | — | WO | claimed |
| WO-2025024500-A1 | METHODS AND SYSTEMS FOR TRANSDERMAL IMMUNOTHERAPY | Passport Technologies, Inc. (US) | 2025-01-30 | — | — | WO | disclosed |
| WO-2024081715-A2 | LIPID NANOPARTICLE (LNP) COMPOSITIONS FOR PLACENTA-SELECTIVE CARGO DELIVERY, AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-04-18 | — | — | WO | disclosed |
| EP-4301405-A1 | VLP ENTEROVIRAL VACCINES | ModernaTX, Inc. (US) | 2024-01-10 | — | — | EP | disclosed |
| EP-1282403-A1 | NON-INVASIVE GENE TARGETING TO THE BRAIN | The Regents of the University of California (US) | 2003-02-12 | — | — | EP | disclosed |
| WO-2002056831-A2 | IMMUNOGENIC PROTEOLIPOSOMES, AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2002-07-25 | — | — | WO | disclosed |
| WO-2001082900-A1 | NON-INVASIVE GENE TARGETING TO THE BRAIN | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-11-08 | — | — | WO | disclosed |